Our Pricing

Understanding Voy Mounjaro: Your Complete UK Guide to Tirzepatide Weight Loss Treatment

Published on: June 03, 2026

If you're searching for voy mounjaro in the UK, you're looking for Mounjaro (tirzepatide), a prescription weight loss injection now available through UK-registered online pharmacies. Mounjaro has demonstrated remarkable efficacy in clinical trials, with participants achieving average weight reductions of up to 22.5% over 72 weeks in the SURMOUNT-1 trial [1]. At Cured Pharmacy, we provide genuine UK-licensed Mounjaro from £124.99, subject to clinical assessment by our UK-registered prescribers.

What Is Voy Mounjaro and How Does It Work?

Voy Mounjaro refers to Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [2]. Unlike single-hormone treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, providing enhanced metabolic benefits.

The medication works by reducing appetite, slowing gastric emptying, and improving insulin sensitivity. Clinical data from the SURMOUNT trials showed that patients on the highest maintenance dose (15 mg) achieved mean body weight reductions of 20.9% compared to 3.1% with placebo over 72 weeks [1]. Mounjaro is administered once weekly via subcutaneous injection using a pre-filled KwikPen device.

Voy Mounjaro Dosing Schedule and Treatment Protocol

The voy Mounjaro treatment begins with a gradual dose escalation to minimise gastrointestinal side effects. Patients typically start with 2.5 mg once weekly for four weeks, then increase to 5 mg for the next four weeks [3]. Further dose increases to 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg occur at four-week intervals, based on individual tolerance and weight loss response.

Our UK prescribers at Cured Pharmacy assess each patient's medical history, current medications, and weight management goals before approving treatment. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical protocols to ensure patient safety and regulatory compliance. Dose adjustments may be delayed if gastrointestinal symptoms are significant, and not all patients require escalation to the maximum 15 mg dose.

Injection Technique and Storage Requirements

Mounjaro should be injected subcutaneously into the abdomen, thigh, or upper arm, rotating injection sites weekly to prevent lipodystrophy. The KwikPen device is designed for ease of use, with clear dosing windows and audible clicks confirming dose delivery. Pens must be stored in a refrigerator at 2-8°C and protected from light, though they may be kept at room temperature (up to 30°C) for up to 21 days if needed [3].

Clinical Evidence Supporting Voy Mounjaro for Weight Loss

The efficacy of voy Mounjaro is supported by the comprehensive SURMOUNT clinical trial programme, which enrolled over 5,000 adults with obesity or overweight. In SURMOUNT-1, 91% of participants on tirzepatide 15 mg achieved at least 5% body weight reduction, compared to 35% in the placebo group [1]. Additionally, 57% of those on the highest dose achieved 20% or greater weight loss, a threshold rarely seen with earlier weight management medications.

Beyond weight reduction, tirzepatide demonstrated significant improvements in cardiometabolic risk factors. Participants experienced reductions in waist circumference, blood pressure, triglycerides, and HbA1c levels, even among those without diabetes at baseline [2]. These comprehensive metabolic benefits position Mounjaro as a leading option for patients seeking substantial, sustained weight loss under medical supervision.

Common Side Effects of Voy Mounjaro and Management Strategies

Like all GLP-1 receptor agonists, voy Mounjaro commonly causes gastrointestinal side effects, particularly during dose escalation. The most frequently reported adverse events include nausea (affecting up to 33% of patients), diarrhoea, vomiting, constipation, and abdominal discomfort [3]. These symptoms are typically mild to moderate, transient, and diminish as the body adapts to the medication.

To minimise side effects, patients should eat smaller, more frequent meals, avoid high-fat foods, and stay well-hydrated. If nausea persists, delaying dose escalation by an additional four weeks often improves tolerance. Serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Our clinical team provides comprehensive guidance on symptom management and when to seek medical attention.

Contraindications and Precautions

Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [3]. It should not be used during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception during treatment and for at least four weeks after discontinuation. Patients with severe gastrointestinal disease, diabetic retinopathy complications, or a history of pancreatitis require careful evaluation before starting tirzepatide.

Where to Buy Voy Mounjaro Safely in the UK

When seeking voy Mounjaro in the UK, it is essential to use a registered pharmacy operating under GPhC oversight. Cured Pharmacy (GPhC Registration Number 9012511) provides genuine UK-licensed Mounjaro from £124.99, with all prescriptions issued by qualified UK prescribers following a thorough online consultation. Patients receive their medication in discreet packaging with next-day delivery options available.

Beware of unregulated websites offering Mounjaro without a prescription or at suspiciously low prices, as these may supply counterfeit or improperly stored medications. The MHRA has issued warnings about fake weight loss injections circulating online, which may contain incorrect doses, contaminants, or no active ingredient at all [4]. Always verify that your pharmacy displays a valid GPhC registration and requires a clinical assessment before dispensing prescription medicines.

Cost of Voy Mounjaro and How to Save with Cured Pharmacy

The cost of voy Mounjaro varies depending on the dose and supply duration. At Cured Pharmacy, prices start from £124.99 for a four-week supply, representing competitive UK pricing for this premium weight loss treatment. New patients can Save £20 off their first order using code Weightlossnew, reducing the initial cost to £124.99. Unlike some providers, we display transparent pricing before consultation, so there are no hidden fees or surprise charges.

We accept all major payment methods and offer flexible subscription options for ongoing treatment, ensuring continuity of care without the need to reorder manually each month. Our clinical team monitors patient progress and adjusts dosing as needed, with regular follow-up consultations included in the service. For patients seeking the cheapest UK price on genuine Mounjaro with comprehensive clinical support, Cured Pharmacy delivers exceptional value and service quality.

NHS vs Private Prescription Costs

Mounjaro is not yet routinely available through NHS weight management services, though NICE is currently evaluating its cost-effectiveness for potential future inclusion. Most UK patients access tirzepatide through private prescriptions, either via in-person consultations or registered online pharmacies. Private prescriptions eliminate waiting lists and provide faster access to treatment, with the convenience of home delivery and ongoing remote clinical support.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 13 August 2026]
3. Eli Lilly and Company. (2024). Mounjaro (tirzepatide) injection prescribing information. UK Summary of Product Characteristics. [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Falsified weight-loss injectable medicines found in the UK. Drug Safety Update, 16(11), A1. [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.